Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,393.00
-44.00 (-3.06%)
Apr 2, 2026, 1:28 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 24.85 billion as of April 1, 2026. Its market cap has decreased by -45.91% in one year.
Market Cap
24.85B
Enterprise Value
23.43B
Revenue
1.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,393.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 24.85B, a decrease of -72.45%. That is a compound annual growth rate of -52.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 24.85B | -13.49% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 202.57B |
| Vaxcell-Bio Therapeutics | 188.15B |
| Macrogen | 177.04B |
| ENCell | 175.65B |
| iNtRON Biotechnology | 125.07B |
| Amicogen | 114.49B |
| CG Invites | 114.03B |
| IMB Dx | 99.25B |